Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CLNN - Clene Inhibikase Therapeutics leads healthcare gainers; IMV Tempest Therapeutics among major losers

CLNN - Clene Inhibikase Therapeutics leads healthcare gainers; IMV Tempest Therapeutics among major losers

Clene Inc.
Gainers: Clene (CLNN) +8%, Inhibikase Therapeutics (IKT) +7%, ASLAN Pharmaceuticals (ASLN) +5%, Doximity (DOCS) +5%.Losers: IMV (IMV) -26%, Tempest Therapeutics (TPST) -25%, Sonoma Pharmaceuticals (SNOA) -23%, Immunic (IMUX) -18%, Virpax Pharmaceuticals (VRPX) -17%.

For further details see:

Clene, Inhibikase Therapeutics leads healthcare gainers; IMV, Tempest Therapeutics among major losers
Stock Information
Company Name: Clene Inc.
Stock Symbol: CLNN
Market: NASDAQ
Website: clene.com
Menu
CLNN CLNN Quote CLNN Short CLNN News CLNN Articles CLNN Message Board
Get CLNN Alerts

News, Short Squeeze, Breakout and More Instantly...